(Q34975678)

5 August 2017

1 reference

title

Cefditoren, a new aminothiazolyl cephalosporin (English)

1 reference

5 August 2017

Ebrahim A Balbisi

1

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

22

1 reference

5 August 2017

issue

10

1 reference

5 August 2017

page(s)

1278-1293

1 reference

In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.15.1278.33481

In vitro activity of a new cephalosporin ME-1206 compared with other agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.15.1278.33481

Cefditoren activity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.15.1278.33481

In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.15.1278.33481

In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.15.1278.33481

Activity of cefditoren against beta-lactamase-positive and -negative Haemophilus influenzae and Moraxella catarrhalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.15.1278.33481

In vitro and in vivo antibacterial activity and pharmacokinetics of SC-002 and its derivative, SC-004: new oral cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.15.1278.33481

In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and penicillin-intermediate strains of Streptococcus pneumoniae isolated in Germany, 1992-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.15.1278.33481

Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.15.1278.33481

Comparative activity of cefditoren and other oral beta-lactams against nonpneumococcal streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.15.1278.33481

10.1592/PHCO.22.15.1278.33481

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference